These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 18977253)
21. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice. Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490 [TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease. Liu LX; Chen WF; Xie JX; Wong MS Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104 [TBL] [Abstract][Full Text] [Related]
23. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N. Pérez V; Morón J; Pastó M; Unzeta M Neurobiology (Bp); 2000; 8(3-4):231-6. PubMed ID: 11225513 [TBL] [Abstract][Full Text] [Related]
25. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice. Mizukawa K; Ogawa N; Sora YH Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432 [TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha receptor ablation in a chronic MPTP mouse model of Parkinson's disease. Leng A; Mura A; Feldon J; Ferger B Neurosci Lett; 2005 Feb; 375(2):107-11. PubMed ID: 15670651 [TBL] [Abstract][Full Text] [Related]
27. Manganese does not alter the severe neurotoxicity of MPTP. Baek SY; Kim YH; Oh SO; Lee CR; Yoo CI; Lee JH; Lee H; Sim CS; Park J; Kim JW; Yoon CS; Kim Y Hum Exp Toxicol; 2007 Mar; 26(3):203-11. PubMed ID: 17439923 [TBL] [Abstract][Full Text] [Related]
28. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse. Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356 [TBL] [Abstract][Full Text] [Related]
29. GDNF applied to the MPTP-lesioned nigrostriatal system requires TGF-beta for its neuroprotective action. Schober A; Peterziel H; von Bartheld CS; Simon H; Krieglstein K; Unsicker K Neurobiol Dis; 2007 Feb; 25(2):378-91. PubMed ID: 17141511 [TBL] [Abstract][Full Text] [Related]
30. Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP. Betarbet R; Greenamyre JT Exp Neurol; 2004 Oct; 189(2):393-403. PubMed ID: 15380489 [TBL] [Abstract][Full Text] [Related]
31. Changes in cytoskeletal gene expression linked to MPTP-treatment in Mice. Cuadrado-Tejedor M; Sesma MT; Giménez-Amaya JM; Ortiz L Neurobiol Dis; 2005 Dec; 20(3):666-72. PubMed ID: 16005240 [TBL] [Abstract][Full Text] [Related]
32. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Kang JM; Park HJ; Choi YG; Choe IH; Park JH; Kim YS; Lim S Brain Res; 2007 Feb; 1131(1):211-9. PubMed ID: 17173870 [TBL] [Abstract][Full Text] [Related]
33. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. Aoki E; Yano R; Yokoyama H; Kato H; Araki T Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004 [TBL] [Abstract][Full Text] [Related]
34. Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum. Singh S; Singh K; Gupta SP; Patel DK; Singh VK; Singh RK; Singh MP Brain Res; 2009 Aug; 1283():115-26. PubMed ID: 19520064 [TBL] [Abstract][Full Text] [Related]
35. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265 [TBL] [Abstract][Full Text] [Related]
36. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793 [TBL] [Abstract][Full Text] [Related]